Article ISI
Pharmacogenomics. 2012; 13(15):1711-1717  (2012)

Losartan hydroxylation phenotype in an Ecuatorian population: influence of CYP2C9 genetic polymorphism, habits and gender.

Dorado P, Beltrán LJ, Machín E, Peñas-Lledó EM, Terán E, Llerena A; CEIBA.FP Consortium of the Ibero-American Network of Pharmacogenetics and Pharmacogenomics RIBEF. Moya GE, Ferreiro V, Tarazona-Santos E, Fiedler J, Herrera L, Rojas-Ponce R (12) et al.